$4550
$3640
The enteral nutrition market is expected to reach US$ 16,185.64 Mn in 2027 from US$ 8,611.49 Mn in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027.
The report provides trends prevailing in the global enteral nutrition market and the factors driving the market along with those that act as hindrances. The increasing incidence of malnutrition and rising number of patients suffering with chronic diseases are anticipated to drive the growth of the market. However, the complications associated with enteral nutrition is likely to hamper the growth of the market.
Lucrative Regional Enteral Nutrition Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities

- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing malnutrition worldwide
Malnutrition is a state of an individual pertaining to nutrition in which a deficiency or excess or imbalance of energy, protein and other nutrients leads to measurable adverse effects on tissue/body form in terms of body shape, size and composition as well as function and clinical outcome. Infections such as measles, malaria and diarrhea are highly prevalent in the society that results into acute malnutrition, majorly among infants and children.
Malnutrition is one of the universal problem that is prevalent in all the countries around the world. According to the World Health Organization, one third of the female that falls under reproductive age are anemic, whereas 39% of the adults across the world are obese or overweight. Moreover, the data findings by WHO also states that every year around 20 million newborn babies born are overweight. The Global Nutrition Report of 2018 states that malnutrition and its associated costs may cause a global burden of approximately US$ 3.5 trillion annually. Thus, the government support along with increasing cases of malnutrition across the world is expected to promote the growth of enteral nutritional supplements over the coming years.
Increasing Online Distribution Platforms
During recent years, larger platforms such as Zalando, Amazon and others are increasingly dominating the digital distribution across the globe. In the past few years, the number of online medical supply retailers and mass distributors have increased by a significant rate due to ease of purchase and customer friendly services offered by these channels. The internet has disrupted the conventional model of medical nutrition supplement distribution by giving the consumers new choices as well as control over the ways to manage their wellbeing and health. According to the National Health Services, an estimated of four out of five people in the US check the medical products online before consulting a physician and also verifies price difference between retail stores and online pharmacies. The NHS also states that similar trends are also reflected in the UK. Furthermore, improved patient-provider communication and promotional campaigns are likely to induce the growth of online distribution in case of enteral nutrition products for short-term and long term care among critically ill patients.
Form Insights
The enteral nutrition market on the basis of form is segmented in to liquid and powder. In 2018, the liquid segment accounted for the largest market share in the global enteral nutrition market by form. The liquid formulations are easy to be tube-fed in patients that have difficulties in chewing and swallowing and does not require reconstitution in a liquid base like the powder counterparts. Furthermore, the liquid form has also shown results to be well-tolerated by patients making them a preferred option over powdered forms.
Enteral nutrition Market, by Form
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Enteral Nutrition Market: Strategic Insights
Market Size Value in US$ 8,611.49 Million in 2018 Market Size Value by US$ 16,185.64 Million by 2027 Growth rate CAGR of 7.4% from 2019-2027 Forecast Period 2019-2027 Base Year 2019
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Enteral Nutrition Market: Strategic Insights

Market Size Value in | US$ 8,611.49 Million in 2018 |
Market Size Value by | US$ 16,185.64 Million by 2027 |
Growth rate | CAGR of 7.4% from 2019-2027 |
Forecast Period | 2019-2027 |
Base Year | 2019 |

Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Some of the activities undertaken by the companies, which have promoted its growth are, majorly organic developments. Companies such as Abbott, Nestle SA and Danone SA among others have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the enteral nutrition market. The companies have utilized strategies such as product launches, and approvals of their product portfolio and area expansion for the growth of their organizations.
Global Enteral Nutrition Market – By Form
- Liquid
- Powder
Global Enteral Nutrition Market – By Nutrient Composition
- Protein-Based
- Standard Protein Diet
- High Protein Supplement
- Protein for Diabetic Patients
- Other Composition Types
- Carbohydrates Based
- Fat Based
- Vitamin Based
- Others
Global Enteral Nutrition Market – By Product Size
- Table-Top
- Benchtop
- Standalone
Global Enteral Nutrition Market – By Distribution Channel
- Hospitals
- Retail Pharmacies
- Online Pharmacies
BY GEOGRAPHY
North America
- U.S.
- Canada
- Mexico
Europe
- France
- Germany
- UK
- Spain
- Italy
Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
Middle East & Africa (MEA)
- Saudi Arabia
- South Africa
- UAE
South and Central America
- Brazil
- Argentina
Company Profiles
- B. Braun Melsungen AG
- Global Health Products, Inc.
- Meiji Holdings Co., Ltd.
- Victus, Inc.
- Hormel Foods Corporation
- Abbott
- Nestlé S.A.
- Danone SA
- Fresenius Kabi AG
- Mead Johnson Nutrition Company

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Form ; Nutrient Composition ; Distribution Channel , and Geography

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Frequently Asked Questions
The price of enteral nutrition supplements lies between the ranges of US$ 40-400, per package of varying volumes. However, the cost profoundly differs based upon the customization, i.e., the type of enteral supplement for particular disease, brand value and others. Also, the cost of enteral nutrition supplements depends based on the location of the manufacturer depending upon the raw materials and the demand for the products.
Enteral nutrition refers to food supplements and products that are consumed via gastrointestinal (GI) tract. This type of nutrition is recommended to patients that has an injury or a medical condition that prevents regular intake of food through the mouth or for the people that have difficulties in swallowing or chewing.
The increasing incidence of malnutrition and rising number of patients suffering with chronic diseases are anticipated to drive the growth of the market. However, the complications associated with enteral nutrition are likely to hamper the growth of the market. On the other, booming e-commerce and online distribution of medical products are likely to be prevalent trends in the enteral nutrition market over the coming years.
The List of Companies
- B. Braun Melsungen AG
- Global Health Products, Inc.
- Meiji Holdings Co., Ltd.
- Victus, Inc.
- Hormel Foods Corporation
- Abbott
- Nestlé S.A.
- Danone SA
- Fresenius Kabi AG
- Mead Johnson Nutrition Company
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports

Dec 2019
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography

Dec 2019
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography

Dec 2019
Drug Delivery Market
Forecast to 2028 - Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)

Dec 2019
Enteral and Parenteral Medical Nutrition Market
Forecast to 2028 - Global Analysis by Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer's Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole–Source), Form (Liquid, Powder, and Semi–Solid), Product Type (General and Disease–Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18–60 Years, 3–18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)

Dec 2019
CIN & HR-HPV Treatment Market
Forecast to 2028 - Global Analysis By Disease Type (Cervical Intraepithelial Neoplasia 1, Cervical Intraepithelial Neoplasia 2, and Cervical Intraepithelial Neoplasia 3), Strain Type (HPV 16, HPV 18, and Others), Offering (Diagnostic Method and Treatment), Product Type (Kits & Reagents, Instruments, and Services), and End User (Hospitals & Clinics, Diagnostic Laboratories, Specialized Clinical Laboratories, and Others)

Dec 2019
Pharmaceutical Fluid Handling Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Offering (Equipment & Solutions and Services), Tubing (Thermoplastic Elastomers, Polyvinyl Chloride, and Silicone), Application (Fluid Handling & Management, Fluid Preparation, Integration & Automation, Buffer Management, and Others), Usage (Cough Syrup, Intravenous Product, Complex Active Pharmaceutical Ingredients, and Others), and End User (Biotechnology Companies, Pharmaceutical & Medical Companies, and Others)

Dec 2019
Enteral Medical Nutrition Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Indication (Respiratory Disorders, Cancer, Post COVID-19, Gastrointestinal Disorders, Liver Failure, and Others), Nutrition Type (Supplemental and Sole-Source), Form (Powder, Liquid, and Semi-Solid), Product (Standard Protein Diet, High Protein Diet, Fruit Juice Based Oral Nutritional Supplement, and Others), Distribution Channel (Hospital Pharmacies, Retail Stores, and Others), and Age Group [Child (Till 18 Years) and Adults (18+years)]

Dec 2019
Glycomic Therapeutics Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Class (Isolated and Synthetic), Structures [Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins & Heparin Based Glycans, Targeting Glycosphingolipids, and Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate; Erythropoietin & Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 & 3; Beta & Gamma Interferons; and Others]